The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998–2008: a nation-wide cancer registry-based study
作者： Nai-Jung Chiang , Li-Tzong Chen , Chia-Rung Tsai , Jeffrey S Chang
关键词:
摘要: Background To investigate the incidence of gastrointestinal stromal tumors (GISTs) in Taiwan and impact imatinib on overall survival (OS) GIST patients.
biomedcentral.com
springer.com
paperity.org参考文章(36)
Peter McIntyre, Ruth Jepson, Stephen Leeder, Les Irwig, The outcome of childhood Haemophilus influenzae meningitis. A population based study. The Medical Journal of Australia. ,vol. 159, pp. 766- 772 ,(1993) , 10.5694/J.1326-5377.1993.TB141344.X
Geneviève Monges, Ségolène Bisot-Locard, Jean-Yves Blay, Anne-Marie Bouvier, Marisol Urbieta, Jean-Michel Coindre, Jean-Yves Scoazec, The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists. Bulletin Du Cancer. ,vol. 97, ,(2010) , 10.1684/BDC.2010.1041
Kam Hoi Chan, Chun Wing Chan, Wai Hung Chow, Wai Keung Kwan, Chi Kwan Kong, Ka Fung Mak, Miu Yi Leung, Lin Kiu Lau, None, Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World Journal of Gastroenterology. ,vol. 12, pp. 2223- 2228 ,(2006) , 10.3748/WJG.V12.I14.2223
Richard Pazdur, Mark Rothmann, Donna Griebel, Ann Staten, Jogarao Gobburu, Atiqur Rahman, Gang Chen, Gabriel Robbie, Gene Williams, Martin Cohen, Ramzi Dagher, Approval Summary Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors Clinical Cancer Research. ,vol. 8, pp. 3034- 3038 ,(2002)
Markku Miettinen, Jerzy Lasota, Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis Archives of Pathology & Laboratory Medicine. ,vol. 130, pp. 1466- 1478 ,(2006) , 10.1043/1543-2165(2006)130[1466:GSTROM]2.0.CO;2
Yukihiko Kitamura, Seiichi Hirota, Toshirou Nishida, Gastrointestinal stromal tumors (GIST): A model for molecule-based diagnosis and treatment of solid tumors Cancer Science. ,vol. 94, pp. 315- 320 ,(2003) , 10.1111/J.1349-7006.2003.TB01439.X
Bengt Nilsson, Per Bümming, Jeanne M. Meis-Kindblom, Anders Odén, Aydin Dortok, Bengt Gustavsson, Katarzyna Sablinska, Lars-Gunnar Kindblom, Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer. ,vol. 103, pp. 821- 829 ,(2005) , 10.1002/CNCR.20862
Jerry Call, Christopher D Walentas, Jens C Eickhoff, Norman Scherzer, Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry BMC Cancer. ,vol. 12, pp. 90- 90 ,(2012) , 10.1186/1471-2407-12-90
Theresa S. Emory, Leslie H. Sobin, Laura Lukes, Dong H. Lee, Timothy J. O'Leary, Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. The American Journal of Surgical Pathology. ,vol. 23, pp. 82- 87 ,(1999) , 10.1097/00000478-199901000-00009
Brian M. Yan, Gilaad G. Kaplan, Stefan Urbanski, Carla L. Nash, Paul L. Beck, Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. International Journal of Surgical Pathology. ,vol. 16, pp. 241- 250 ,(2008) , 10.1177/1066896907306967